A. Svedbom and M. Ståhle, “Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study”, Acta Derm Venereol, vol. 103, p. adv7138, Aug. 2023.